A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

NCT01095653 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1179

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Dapagliflozin
DRUG: Dapagliflozin
DRUG: Metformin
DRUG: Dapagliflozin Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]